• TFBS Bioscience登載於日本經濟產業省公佈的「再生醫療等製品CDMO企業名單」

  2025-04-30 TFBS Bioscience登載於日本經濟產業省公佈的「再生醫療等製品CDMO企業名單」 TFBS Bioscience登載於日本經濟產業省公佈的「再生醫療等製品CDMO企業名單」 Learn more

• 啟弘生技竹北新廠正式啟用，台灣邁向國際病毒載體代工

  2024-10-23 啟弘生技竹北新廠正式啟用，台灣邁向國際病毒載體代工 台灣首家GMP等級病毒載體量產廠—啟弘生技（TFBS Bioscience Inc.）竹北新廠，正式開幕，標誌著台灣細胞與基因治療產業邁向商業化階段的重大里程碑，也彰顯了台灣生技產業CDMO逐漸在全球的供應鏈中佔據關鍵地位 Learn more

• Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy

  2024-10-02 Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy Minaris Regenerative Medicine, LLC (Minaris) and TFBS Bioscience Inc. (TFBS) are pleased to announce a strategic partnership in cell and gene therapy (CGT) mainly in North America. This collaboration is designed to enhance their capabilities to drive industry innovation by providing the one-stop-shop solutions. Learn more

• 基米與啟弘簽MOU 開啟細胞及基因治療檢測新局

  2024-08-15 基米與啟弘簽MOU 開啟細胞及基因治療檢測新局 基龍米克斯生物科技股份有限公司（以下簡稱“基米”，股票代碼：4195）與啟弘生物科技股份有限公司（以下簡稱“啟弘”，股票代碼：6939）今（15）日宣布簽署合作備忘錄，將結合雙方優勢，打造強化細胞及基因治療（CGT）產品的次世代基因定序（NGS）檢測平台，未來也將共同進行推廣，搶攻龐大再生醫療市場商機。 Learn more

• President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA

  2024-05-08 President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA Learn more